{"id":3140,"date":"2026-04-11T23:32:14","date_gmt":"2026-04-11T23:32:14","guid":{"rendered":"https:\/\/www.europesays.com\/ai\/3140\/"},"modified":"2026-04-11T23:32:14","modified_gmt":"2026-04-11T23:32:14","slug":"clarivate-plc-clvt-expands-intelligent-automation-across-regulatory-workflows","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ai\/3140\/","title":{"rendered":"Clarivate Plc (CLVT) Expands Intelligent Automation across Regulatory Workflows"},"content":{"rendered":"\n

Clarivate Plc (NYSE:CLVT<\/a>) is one of the best cheap penny stocks to buy that aren\u2019t scams<\/a>. On March 10, Clarivate Plc (NYSE:CLVT) affirmed its commitment to extending proprietary intelligence into enterprise AI ecosystems.<\/p>\n

\"Clarivate Clarivate Plc (CLVT) Expands Intelligent Automation across Regulatory Workflows <\/p>\n

The company is integrating its proprietary regulatory intelligence data under Cortellis Regulatory Intelligence (CRI) with Anthropic Claude\u2019s AI reasoning capabilities. The integration will provide biopharma, biotech, MedTech, and clinical research organizations with intelligent, context-aware access to crucial regulatory data through artificial intelligence workflows.<\/p>\n

In addition, Clarivate stands to extend its regulatory intelligence into the AI environments customers already use while also expanding ecosystems that inform critical decisions. The connection to Claude will offer customers an opportunity to build agents that combine CRI with Internal data and approved external sources.<\/p>\n

The strategic integration with Claude aligns with Clarivate\u2019s strategy of extending intelligence into AI ecosystems where critical decisions are made. It also paves the way for expanding the reach of trusted regulatory insights.<\/p>\n

Clarivate Plc (NYSE:CLVT) is a global information services and analytics company that accelerates innovation by providing trusted insights, data, and software to organizations in research, intellectual property (IP), and life sciences. It owns prominent brands like Web of Science, Cortellis, and Derwent, helping clients manage patents, conduct academic research, and speed up drug development.<\/p>\n

While we acknowledge the potential of CLVT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock<\/a>.<\/p>\n

READ NEXT: 0.28% Percent of George Soros\u2019 Stock Portfolio Is in These 10 Small-Cap Stocks<\/a> and 7 Must-Buy Non-Tech Stocks to Invest in Now<\/a>.<\/p>\n

Disclosure: None. Follow Insider Monkey on Google News<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"Clarivate Plc (NYSE:CLVT) is one of the best cheap penny stocks to buy that aren\u2019t scams. On March…\n","protected":false},"author":2,"featured_media":3141,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[24,1147,3154,25,3156,3157,3155,3153,3159,3158],"class_list":{"0":"post-3140","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-ai","8":"tag-ai","9":"tag-ai-stock","10":"tag-anthropic-claude","11":"tag-artificial-intelligence","12":"tag-clarivate","13":"tag-clarivate-plc","14":"tag-clinical-research-organizations","15":"tag-cortellis-regulatory-intelligence","16":"tag-critical-decisions","17":"tag-regulatory-data"},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/posts\/3140","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/comments?post=3140"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/posts\/3140\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/media\/3141"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/media?parent=3140"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/categories?post=3140"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/tags?post=3140"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}